IL103203A0 - Increased expression of low molecular weight recombinant polypeptides - Google Patents

Increased expression of low molecular weight recombinant polypeptides

Info

Publication number
IL103203A0
IL103203A0 IL103203A IL10320392A IL103203A0 IL 103203 A0 IL103203 A0 IL 103203A0 IL 103203 A IL103203 A IL 103203A IL 10320392 A IL10320392 A IL 10320392A IL 103203 A0 IL103203 A0 IL 103203A0
Authority
IL
Israel
Prior art keywords
molecular weight
low molecular
increased expression
recombinant polypeptides
weight recombinant
Prior art date
Application number
IL103203A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL103203A0 publication Critical patent/IL103203A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/60Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/65Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL103203A 1991-09-24 1992-09-17 Increased expression of low molecular weight recombinant polypeptides IL103203A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/764,655 US5378613A (en) 1991-09-24 1991-09-24 Method for increased expression of low molecular weight recombinant polypeptides

Publications (1)

Publication Number Publication Date
IL103203A0 true IL103203A0 (en) 1993-02-21

Family

ID=25071354

Family Applications (1)

Application Number Title Priority Date Filing Date
IL103203A IL103203A0 (en) 1991-09-24 1992-09-17 Increased expression of low molecular weight recombinant polypeptides

Country Status (8)

Country Link
US (1) US5378613A (de)
EP (1) EP0534705A3 (de)
JP (1) JPH05304978A (de)
AU (1) AU655316B2 (de)
CA (1) CA2079027A1 (de)
HU (1) HUT62659A (de)
IL (1) IL103203A0 (de)
MX (1) MX9205312A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3406244B2 (ja) * 1999-04-30 2003-05-12 伊藤ハム株式会社 新規な融合蛋白質からの組み換えインスリンの製造方法
EP1183357A2 (de) * 1999-05-20 2002-03-06 Scios Inc. Vaskuläre endothelzellen wachstumsfaktordimere
AU5023300A (en) * 1999-05-20 2000-12-12 Scios Inc. Vascular endothelial growth factor variants
DE60120372T2 (de) 2000-03-24 2007-07-05 Genentech Inc., San Francisco Verwendung von insulin zur behandlung von knorpelkrankheiten
KR100847386B1 (ko) 2000-12-26 2008-07-18 몬산토 테크놀로지 엘엘씨 소마토트로핀의 발현을 위한 재조합 dna 벡터
WO2012048856A1 (en) * 2010-10-12 2012-04-19 Glucometrix Pvs Gmbh Proinsulin with helper sequence
EP2867250A2 (de) * 2012-04-04 2015-05-06 GlucoMetrix AG Proinsulin mit verbesserter helfersequenz

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782139A (en) * 1985-10-28 1988-11-01 Eli Lilly And Company Selective chemical removal of a protein amino-terminal residue
EP0371041A1 (de) * 1987-06-24 1990-06-06 Novo Nordisk A/S Verfahren für die herstellung eines proteins oder polypeptides, dns-sequenz, die dieses polypeptid kodiert, mikroorganismus, der diese dns-sequenz beinhaltet, sowie das polypeptid und seine verwendung als pharmazeutisches präparat
IL91771A0 (en) * 1988-09-30 1990-06-10 Lilly Co Eli Increased expression of small molecular weight recombinant proteins
US5158875A (en) * 1989-08-25 1992-10-27 Amgen Inc. Production of biologically active insulin-like growth factor i from high expression host cell systems
US5304473A (en) * 1991-06-11 1994-04-19 Eli Lilly And Company A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production

Also Published As

Publication number Publication date
EP0534705A2 (de) 1993-03-31
HU9203032D0 (en) 1992-11-30
JPH05304978A (ja) 1993-11-19
AU2528092A (en) 1993-03-25
AU655316B2 (en) 1994-12-15
EP0534705A3 (en) 1994-12-14
MX9205312A (es) 1993-07-01
US5378613A (en) 1995-01-03
HUT62659A (en) 1993-05-28
CA2079027A1 (en) 1993-03-25

Similar Documents

Publication Publication Date Title
ZA921882B (en) Recombinant human factor viii derivatives
FI934015L (fi) Pegylation av polypeptider
EP0861893A3 (de) Hohe expression von immunglobulinen
FI933757L (fi) Expression av rekombinantproteiner i attenuerade bakterier
ZA896459B (en) Recombinant saccharomyces
AP9200457A0 (en) New peptides derivatives
ZA928511B (en) Peptides
EP0692499A3 (de) Polyalk-1-ene mit hohen Molmassen
GB2218102B (en) Calcitonin peptide derivatives
HUT58371A (en) Recombinant virus of marek-disease
EP0444149A4 (en) High molecular weight human angiogenic factors
EP0335819A3 (en) Preparation of ultra-high molecular weight polyester
ZA896914B (en) Stable bioactive somatotropins
ZA895137B (en) Novel peptides
IL103203A0 (en) Increased expression of low molecular weight recombinant polypeptides
IL103462A0 (en) Preparation of recombinant borrelia proteins
GB9104596D0 (en) Production of recombinant proteins
AU2297792A (en) Therapeutic polypeptides based on von willebrand factor
IL91771A0 (en) Increased expression of small molecular weight recombinant proteins
FI890175A7 (fi) Ihmisen yhdistelmä-interleukiini-1-a-polypeptidejä
ZA922067B (en) Chimaeric polypeptides
AU2542888A (en) Low molecular weight xylanase glycoprotein
AU3231189A (en) Recombinant endonexin ii
CS56992A3 (en) Analogs of peptides
GB9106568D0 (en) Recombinant antigen